Financhill
Back

Pasithea Therapeutics Corp. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KTTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Pasithea Therapeutics Corp. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.75 Buy
20-day SMA: 0.79 Sell
50-day SMA: 0.8 Sell
200-day SMA: 0.81 Sell
8-day EMA: 0.72 Buy
20-day EMA: 0.53 Buy
50-day EMA: 0.29 Buy
200-day EMA: 0.09 Buy

Pasithea Therapeutics Corp. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 46.72 Sell
Chaikin Money Flow: 247185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.76 - 0.84) Sell
Bollinger Bands (100): (0.67 - 1.07) Sell

Pasithea Therapeutics Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pasithea Therapeutics Corp. Stock

Is Pasithea Therapeutics Corp. Stock a Buy?

KTTA Technical Analysis vs Fundamental Analysis

Sell
39
Pasithea Therapeutics Corp. (KTTA) is a Sell

Is Pasithea Therapeutics Corp. a Buy or a Sell?

Pasithea Therapeutics Corp. Stock Info

Market Cap:
18.4M
Price in USD:
0.77
Share Volume:
293.1K

Pasithea Therapeutics Corp. 52-Week Range

52-Week High:
3.79
52-Week Low:
0.28
Sell
39
Pasithea Therapeutics Corp. (KTTA) is a Sell

Pasithea Therapeutics Corp. Share Price Forecast

Is Pasithea Therapeutics Corp. Stock a Buy?

Fundamental Analysis of Pasithea Therapeutics Corp.

Is Pasithea Therapeutics Corp. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.24 per share.

Technical Analysis of Pasithea Therapeutics Corp.

Should I short Pasithea Therapeutics Corp. stock?

* Pasithea Therapeutics Corp. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.